Home / Uncategorized / FDA approves Erivedge for most common type of skin cancer

FDA approves Erivedge for most common type of skin cancer

Pill is first drug ever approved to treat basal cell carcinoma; BCC strikes 2.8 million Americans each year

Read the original:
FDA approves Erivedge for most common type of skin cancer

If you enjoyed this post, make sure you subscribe to my RSS feed!

About Philippe Matthews

Scroll To Top